account_balance
Investment manager · 13F filer · SEC CIK 2018299
Boxer Capital Management, LLC
Reported value$1.33Bas of Jun 30, 2026
Positions63 12 new, 3 sold out
Top 10 weight65%TNGX alone is 26%
FiledAug 1445 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
TNGX
Tango Therapeutics INC
25.6%
RVMD
Revolution Medicines INC
7.1%
ABVX
Abivax SA
6.1%Added
QURE
Uniqure NV
5.2%Added
KOD
Kodiak Sciences INC
4.3%Added
KYMR
Kymera Therapeutics INC
3.7%Added
DFTX
Definium Therapeutics INC
3.5%Added
REPL
Replimune Group INC
3.3%Added
CELC
Celcuity INC
3.3%Added
QTTB
Q32 Bio INC
3.0%New
53 others
34.9%
Box size is the share of the fund's reported holdings. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
What changed